CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 70,000 shares (option exercise)
- 4 Exercise or conversion VP, CFO, Treasurer, Secretary acquired 22,657 shares (option exercise)
- 4 Open-market sale 10% owner sold 1,354,632 shares at an average $3.26 ($4,411,696)
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 100,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 270,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 483,733 shares (option exercise)
- 4 Exercise or conversion Director acquired 130,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 237,500 shares (option exercise)
- 4 Exercise or conversion VP, CFO, Treasurer, Secretary acquired 53,689 shares (option exercise)
- 4 Exercise or conversion Director acquired 110,004 shares (option exercise)
- 4 Exercise or conversion Director acquired 120,000 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 110,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 19 of 34 · 675 filings